Driebergen-Rijsenburg, Netherlands

Alwin A H A Derijck

This inventor holds 1 USPTO granted patent. Top assignee: Interna Technologies B.v.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alwin A H A Derijck. Retrieved from https://idiyas.com/inventor/alwin-a-h-a-derijck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alwin A H A Derijck: Innovator in Neuronal Therapeutics

Introduction

Alwin A H A Derijck is a notable inventor based in Driebergen-Rijsenburg, Netherlands. He has made significant contributions to the field of neuroscience through his innovative work on miRNA molecules. His research focuses on the therapeutic and diagnostic applications of these molecules in conditions associated with neuronal deficiencies.

Latest Patents

Alwin A H A Derijck holds a patent for a miRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation. This invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent, or a source thereof in addressing neuronal deficiencies and related diseases.

Career Highlights

Alwin A H A Derijck is associated with Interna Technologies B.V., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various neurological conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Alwin collaborates with talented individuals such as Eljo Y Van Battum and Vamshi R Vangoor, contributing to a dynamic research environment that fosters innovation.

Conclusion

Alwin A H A Derijck's contributions to the field of neuroscience through his patented inventions highlight his role as a key innovator in the treatment of neuronal deficiencies. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…